Diuretic therapy in heart and kidney diseases – where are we going wrong?

7th International Congress of Cardionephrology KARNEF (2025) [pp. 103-118]

AUTHOR(S) / АУТОР(И): Sonja Radenković 

Download Full Pdf   

DOI: 10.46793/KARNEF25.107R

ABSTRACT / САЖЕТАК:

Diuretics are the drugs of choice in hypervolemia, given that their main effect is increased elimination of salt and water from the body. Application of diuretics brings with it many challenges and dilemmas, especially when it comes to patients with heart and kidney diseases. In order to avoid mistakes in the treatment of this population, an understanding of the local and systemic effects of the diuretic itself in conditions of altered adaptive mechanisms of the diseased heart and kidneys is necessary.

In daily clinical practice, it is necessary to clearly specify the goals of treatment with diuretics, to evaluate the effectiveness of their application, to solve the problems of diuretic resistance and to use the advantages of diuretic synergism

KEYWORDS / КЉУЧНЕ РЕЧИ:

diuretics, heart and kidney diseases, diuretic efficiency, diuretic resistance, diuretic synergism

REFERENCES / ЛИТЕРАТУРА:

  • Arumugham B, Shahin M. H, Therapeutic Uses of Diuretic Agents StatPearls [Internet] 2023
  • Afsar B, et. al. Focus on renal congestion in heart failure. Clin Kidney J. 2016 Feb;9(1):39-47. doi:10.1093/ckj/sfv124. Epub 2015 Nov 29. PMID: 26798459; PMCID:3PMC4720202
  • Banerjee D, Ali M. A, Wang A. Y. M, Jha V, Acute kidney injury in acute heart failure–when to worry and when not to worry? Nephrol Dial Transplant. 2024 Dec 20;40(1):10-18. https://doi.org/10.1093/ndt/gfae146
  • Bell R, Mandalia R, Diuretics and the kidney BJA Educ. 2022 Apr 20;22(6):216–223. doi:10.1016/j.bjae.2022.02.003
  • Joannidis M, Klein S. J, Ostermann M. 10 myths about frusemide Intens. Care Med (2019) 45:545–548 https://doi.org/10.1007/s00134-018-5502-4201
  • Huang X, Mees E. D, Vos P, Hamza S, Braam B. Everything we always wanted to know about furosemide but were afraid to ask Am J Physiol Renal Physiol. 2016 May 1;310(10):F958-71. doi: 10.1152/ajprenal.00476.2015. Epub 2016 Feb 24
  • Ulu S, Onan E, Management of Cardiovascular Disease in Chronic Kidney Disease Springer Nature Chapter First Online: 25 November 2023 pp 171–197
  • Rodriguez-Espinosa D. et al. Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach Front. Physiol., 2022 08 July Sec. Clin Trans. Physiology Vol 13 – 2022 | https://doi.org/10.3389/fphys.2022.913580
  • Hegde A. Diuretics in Acute Kidney Injury. Indian J Crit Care Med. 2020 Apr;24(Suppl 3): S98-S99. doi: 10.5005/jp-journals-10071-23406. PMID: 32704212; PMCID: PMC7347069
  • Mehta R. L, Pascual M. T, Soroko S, Chertow G. M, PICARD Study Group, Diuretics, Mortality, and Nonrecovery of Renal Function in Acute Renal Failure JAMA. 2002;288(20):2547-2553. doi:10.1001/jama.288.20.2547
  • Georgopoulou T. et al. Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management Clin. Med. 2023, 12(12), 4121; https://doi.org/10.3390/jcm12124121
  • Dilken O, Ince C, Kapucu A, Heeman M, Ergin B. Furosemide exacerbated the impairment of renal function, oxygenation and medullary damage in a rat model of renal ischemia/reperfusion induced AK, 2023 vol 11
  • Peerboom C, Wijne T, Wierenga C. J,Treatment with furosemide indirectly increases inhibitory transmission in the developing hippocampus doi: https://doi.org/10.1101/2023.07.11.548438
  • Panet R, Eliash M, Atlan H, Na+/K+/Cl− cotransporter activates MAP-kinase cascade downstream to protein kinase C, and upstream to MEK J Cell Physiol. 2006 Mar;206(3):578-85. doi:10.1002/jcp.20506.
  • Motwani J. G, Fenwick M. K, Morton J. J, Struthers A. D, Furosemide-Induced Natriuresis Is Augmented by Ultra-Low-Dose Captopril but Not by Standard Doses of Captopril in Chronic Heart Failure 1992Aug;86(2):439-45. doi: 10.1161/01.cir.86.2.439.
  • Jois P, Mebazaa A, Cardio-Renal Syndrome Type 2: Epidemiology, Pathophysiology, and Treatment Seminars in Nephrology 2012 ;32(1):26-30 , DOI: 10.1016/j.semnephrol.2011.11.004
  • Chitturi C, Novak J. E, Diuretics in the Management of Cardiorenal Syndrome. Adv Chr. Kidney Dis. 2018 Sep;25(5):425-433. doi: 10.1053/j.ackd.2018.08.008. PMID: 30309460.
  • Verbrugge F. H, Damman K, Tang W. H. W, Diuretics in cardiorenal syndrome: what’s new? Intensive Care Med. 2018 Mar;44(3):359-362. doi: 10.1007/s00134-017-4834-9.
  • Cox Z. L, Rao V. S, Testani J. M, Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome Kidney360. 2022 Mar 1;3(5):954-967. doi: 10.34067/KID.0006372021. eCollection 2022 May 26. PMID: 36128483
  • Acar S. et al. Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review Int Urol Nephrol. 2021 Sep;53(9):1839-1849. doi:10.1007/s11255-020-02704-7. Epub 2021 Jan 3.
  • Rahman R. et al. Diuretic resistance in heart failure. Cardiology in Review 2021;29(2):p 73-81, DOI: 10.1097/CRD.0000000000000310
  • Wilcox C. S, Testani J. M, Pitt B. Pathophysiology of Diuretic Resistance and Its Implications for the Management of Chronic Heart Failure. Hypertension. 2020 Oct;76(4):1045-1054. doi: 10.1161/HYPERTENSION AHA.120.15205.Epub 2020 Aug 24PMID:32829662; PMCID: PMC10683075
  • Palazzuoli A. et al. The Changing Diuretics in Heart Failure Management across the Last Century J. Clin. Med. 2024, 13, 1674. https://doi.org/10.3390/jcm1306167
  • Cox Z. L, Hung R, Lenihan D. J, Testani J. M, Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial JACC Heart Fail . 2020 Mar;8(3):157-168. doi:10.1016/j.jchf.2019.09.012. Epub 2019 Dec 11
  • Guo L. et al. Diuretic resistance in patients with kidney disease: Challenges and opportunities Biomed Pharmacother. 2023 Jan:157:114058. doi: 10.1016/j.biopha.2022.114058. Epub 2022 Dec5
  • Agarwal R, Verma A, Georgianos P. I, Diuretics in patients with chronic kidney disease Nat Rev Nephrol. 2025 Jan 7. doi: 10.1038/s41581-024-00918-x.
  • Arici M, Management of Chronic Kidney Disease A Clinician’s Guide Book Springer Nature link 2023 Latest edition
  • Vaduganathan M, Kumar V, Voors A. A, Butler J, Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response Expert Review of Cardiovascular Therapy 2015 Volume 13, Issue 10 Pages 1075-1078 https://doi.org/10.1586/14779072.2015.1087313
  • Rao V. S. et at. Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure J Am Coll Cardiol 2021 Feb 16;77(6):695-708.doi: 1016/j.jacc.2020.12.022.
  • Aronson D, Burger A. J,Diuretic response: clinical and hemodynamic predictors and relation to clinical outcomeJ Card Fail2015; 22:193–200. doi: 10.1016/j.cardfail.2015.07.006. Epub Jul 21. PMID: 26209003.
  • Ramírez-Sánchez P. et al. External validation of the natriuretic response prediction equation to discriminate diuretic response in heart failure ESC Heart Fail. 2025 Feb;12(1):668-671. doi:10.1002/ehf2.14801. Epub 2024 Aug 12. PMID: 39135310; PMCID: PMC1176966
  • Zandijk A. J. L. et al. Chloride in Heart Failure: The Neglected Electrolyte State-of-the-art Review JACC: Heart Failure 2021;Vol 9, Issue 12, Pages 904-915
  • Titko T, Perekhoda L, Drapak I, Tsapko Y, Modern trends in diuretics development Eur J Med Chem. 2020 Dec 15:208:112855. doi: 10.1016/j.ejmech.2020.112855. Epub 2020 Sep 19
  • Wagner C. A, Pendrin – A New Target for Diuretic Therapy? J Am Soc Nephrol. 2016 Dec;27(12):3499-3501. doi: 10.1681/ASN.2016070720. Epub 2016 Aug 11. PMID: 27516234; PMCID: PMC5118499
  • Wu L, Rodriguez M, Hachem K. E, Krittanawong C, Diuretic Treatment in Heart Failure: A Practical Guide for Clinicians Clin. Med. 2024, 13(15), 4470; https://doi.org/10.3390/jcm13154470
  • Minutolo R, De Nicola L, Mallamaci F, Zoccali C, Thiazide diuretics are back in CKD: the case of chlorthalidone Clin KidneyJ,2023,Vol:16,Issue1:41–51, https://doi.org/10.1093/ckj/sfac198
  • De la Espriella R, Cobo M, Núñez J, Thiazides in chronic kidney disease: “back to the future” Clin Kidney J, 2023; Vol16, Issue 1, Pages 1–4, https://doi.org/10.1093/ckj/sfac228
  • Kumbhani D. J, Keshavi N, Safety and Efficacy of the Combination of Loop With Thiazide-Type Diuretics in Patients With Decompensated Heart Failure – CLOROTIC American College of Cardiology 2024 Jul 17
  • Chávez-Iñiguez J. S. et al. The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial BMC Nephrol. 2022 Jan 3;23(1):3. doi: 10.1186/s12882-021-02637-y.
  • Supuran C. T. Diuretics: From Classical Carbonic Anhydrase Inhibitors to Novel Applications of the Sulfonamides Curr Pharm Des. 2008;14(7):641-8. doi:10.2174/138161208783877947.
  • Mullens W. et al. Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): Baseline characteristics. Eur. J. Heart Fail. 2022, 24, 1601–1610. doi:10.1002/ejhf.2587. Epub 2022 Jul 12.
  • Delanaye P, Scheen A. J, The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection  Diabetes Metab. 2021 Nov;47(6):101285. doi:10.1016/j.diabet.2021.101285. Epub 2021 Sep 28.
  • Magdy J. S, McVeigh J, Indraratna P, Diuretics in the management of chronic heart failure: when and how Aust Prescr. 2022 Dec;45(6):200-204. doi: 10.18773/austprescr.2022.069. Epub 2022 Nov 30.
  • Escudero V. J. et al. New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide Front. Nephrol., Sec. Critical Care Nephrology 2022 Sec.Volume 2 – 2022 https://doi.org/10.3389/fneph.2022.879766
  • Bikdeli B. et al. Dominance of furosemide for loop diuretic therapy in heart failure: Time to revisit the alternatives? J Am Coll Cardiol. 2013 Apr 9;61(14):1549-50. doi: 10.1016/j.jacc.2012.12.043.
  • Girerd N. et al. Practical outpatient management of worsening chronic heart failure Eur J Heart Fail. 2022 May;24(5):750-761. doi:10.1002/ejhf.2503. Epub 2022 Apr 27. PMID: 35417093; PMCID: PMC9325366
  • Novak J. E, Ellison D. H, Diuretics in States of Volume Overload: Core Curriculum 2022 Am J Kidney Dis. 2022 Aug;80(2):264-276. doi: 10.1053/j.ajkd.2021.09.029. Epub 2022 Feb 19.
  • Mentz R. J. et al. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial 2023;329(3):214-223. doi:10.1001/jama.2022.2392
  • Horiuchi Y, Wettersten N, Treatment strategies for diuretic resistance in patients with heart failure Review Article J Cardiol. 2025 Jan;85(1):1-7. doi: 10.1016/j.jjcc.2024.06.005. Epub 2024 Jun 22
  • Cataliotti A. et al. Brain natriuretic peptide enhances renal actions of furosemide and prevents furosemide-induced aldosterone activation in heart failure Circulation. 2004 Apr